Knights Of Columbus Asset Advisors LLC Zai Lab LTD Transaction History

Knights Of Columbus Asset Advisors LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 16, 2022	BUY	$27.77 - $64.4 $7,553 - $17,516	272 Added 37.06%	1,006 $44,000
Q4 2021 Feb 11, 2022	BUY	$54.9 - $105.21 $439 - $841	8 Added 1.1%	734 $46,000
Q3 2021 Nov 10, 2021	BUY	$105.0 - $178.37 $525 - $891	5 Added 0.69%	726 $77,000
Q2 2021 Aug 12, 2021	BUY	$125.11 - $180.0 $10,384 - $14,940	83 Added 13.01%	721 $128,000
Q1 2021 May 17, 2021	BUY	$126.27 - $191.71 $80,560 - $122,310	638 New	638 $85,000

127

49.6M

223K

588K

Ticker ZLAB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 97,908,704
Market Cap $2.7B
Description
Zai Lab Limited develops and commercializes therapies to treat oncology, autoimmune disorders, infectious diseases, and neuroscience primarily in Mainland China and Hong Kong. The company's commercial products include Zejula, a once-daily small-molecule poly polymerase 1/2 inhibitor; Optune, a device that delivers tumor treating fields; NUZYRA f...

Get notified when there are updates to the investment portfolio of Knights Of Columbus Asset Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Knights Of Columbus Asset Advisors LLC with notifications on news.